What is NeuroPace?
Founded in 1997 and headquartered in Mountain View, California, NeuroPace designs, develops, manufactures, and markets implantable devices for the treatment of neurological disorders using responsive stimulation. The company operates within the highly specialized medical device industry, addressing unmet needs in patient care through advanced technological solutions. Its focus on neurological disorders positions it at the forefront of medical innovation, aiming to improve the quality of life for individuals suffering from conditions requiring advanced therapeutic interventions.
How much funding has NeuroPace raised?
NeuroPace has raised a total of $323.2M across 7 funding rounds:
Private Equity
$49.1M
Private Equity
$18.1M
Series A
$72M
Private Equity
$74M
Debt
$2M
Other Financing Round
$33M
Debt
$75M
Private Equity (2011): $49.1M, investors not publicly disclosed
Private Equity (2013): $18.1M, investors not publicly disclosed
Series A (2016): $72M, investors not publicly disclosed
Private Equity (2017): $74M featuring OrbiMed
Debt (2020): $2M backed by PPP
Other Financing Round (2020): $33M with participation from Revelation Partners, Accelmed Partners, Soleus Capital, OrbiMed, and KCK Group
Debt (2025): $75M led by MidCap Financial
Key Investors in NeuroPace
MidCap Financial
MidCap Financial Investment Corporation is a company that specializes in investment operations, likely providing debt financing or specialized lending solutions to companies in need of capital for growth or operational expansion.
Revelation Partners
Revelation Partners specializes in providing flexible capital solutions for rapidly growing healthcare companies, focusing on shareholder liquidity and growth capital. They partner with management teams to scale businesses and create customized liquidity solutions.
OrbiMed
OrbiMed Advisors LLC operates as a specialized investment firm focused on the healthcare sector, with deep expertise spanning multiple therapeutic and commercial domains, including biopharmaceuticals and medical devices.
What's next for NeuroPace?
With a significant total funding amount and recent strategic investment, NeuroPace is poised for continued growth and development. The company's trajectory suggests a focus on scaling its manufacturing capabilities, expanding clinical trials, and potentially pursuing broader market penetration. Future strategic financing rounds or partnerships may be anticipated as NeuroPace aims to solidify its position as a leader in the neuro-stimulation device market, further innovating in the treatment of complex neurological conditions.
See full NeuroPace company page
